$WSNAF News
Last published 3y ago
- 3y agoLSDIWSNAFWesana Health Announces Sale of SANA-13 Assets to Lucy Scientific DiscoveryGlobeNewswireCHICAGO and TORONTO, March 21, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company, today announced that the Company has entered
- 3y agoWSNAFWesana Health Announces Receipt of Short-Term LoanGlobeNewswireCHICAGO and TORONTO, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company, today announced that Wesana Health Inc.
- 4y agoWSNAFWesana Announces Sale of Clinic Management Services OrganizationGlobeNewswireCHICAGO and TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow, today announces that i
- 4y agoWSNAFWesana Announces Second Quarter 2022 Financial ResultsGlobeNewswireCHICAGO and TORONTO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care
- 4y agoWSNAFWesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic TherapiesGlobeNewswireCHICAGO and TORONTO, June 08, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care
- 4y agoWSNAFWesana Announces First Quarter 2022 Financial ResultsGlobeNewswireCHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care p
- 4y agoWSNAFWesana Health Outlines Accelerated Drug Development PathwayGlobeNewswireCHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care p
- 4y agoWSNAFWesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery AssetsGlobeNewswireCHICAGO and TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa
- 4y agoWSNAFWesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period HighlightsGlobeNewswireCHICAGO and TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care p
- 4y agoWSNAFWesana Health to Present Live at KCSA Virtual Investor Conference April 28thGlobeNewswireCHICAGO and TORONTO, April 27, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new car
- 4y agoWSNAFWesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive DisorderGlobeNewswireConcurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CHICAGO and TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc.�
- 4y agoWSNAFWesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry EventsGlobeNewswireCHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care
- 4y agoWSNAFWesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-DepressantGlobeNewswireCHICAGO and TORONTO, March 22, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care
- 4y agoWSNAFWesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013GlobeNewswireCHICAGO and TORONTO, March 14, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new car
- 4y agoWSNAFWesana Provides Updates on Build-out of Third ClinicGlobeNewswireCHICAGO and TORONTO, March 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care
- 4y agoJSDAWSNAFJones Soda to Launch First-of-its-Kind Nootropic Supplement in Partnership with Mike Tyson and Wesana HealthGlobeNewswireSEATTLE, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Jones Soda Co. (OTCQB:JSDA) ("Jones Soda" or the "Company"), the original craft soda known for its unconventional flavors and user-designed label artwork, Wesana Health ("Wesana") (CSE:WESA, OTCQB:WSNAF), an i
- 4y agoWSNAFWesana Health Appoints Meghna A. Gaeta as Chief Marketing OfficerGlobeNewswireCHICAGO and TORONTO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care
- 4y agoWSNAFWesana Health Announces Positive Findings From Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and CannabidiolGlobeNewswireWesana's novel and proprietary depression treatment protocol that includes a single high dose of psilocybin followed by a maintenance regimen of a microdose of psilocybin combined with cannabidiol, significantly reduced depressive behaviors in a validat
- 4y agoWSNAFWesana Health Provides Strategic and Operational UpdatesGlobeNewswireWesana granted pre-IND meeting with FDA, currently set for March 11, 2022 Wesana Clinics exhibited a record quarter of billings, new patient visits, telemedicine utilization, overall patient appointments, and ketamine administrations New flagship cli
- 4y agoWSNAFWesana Health Granted US FDA Pre-IND Meeting for SANA-013GlobeNewswireCHICAGO and TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care
- 4y agoWSNAFMAPS and Wesana Health Resume NegotiationsGlobeNewswireCHICAGO and TORONTO, Dec. 14, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company, is pleased to announce receipt of a commercial viability analysis conducted b
- 4y agoWSNAFWesana Completes Filing of PCT Patents for Novel Drug ProtocolsGlobeNewswireCHICAGO and TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company, is pleased to announce that it has filed Patent Cooperation Treaty ("PCT") pa
- 4y agoWSNAFWesana Health Reports Q3 2021 Financial ResultsGlobeNewswireCHICAGO and TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data driven life sciences company, has announced its quarterly financial results for the three- and nine-month per
- 4y agoWSNAFWesana Health Clinics Surpass 4,000 Administered Ketamine TreatmentsGlobeNewswireCHICAGO and TORONTO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), a data-driven life sciences company, announced today that the Company's Wesana Clinics business segment has surpasse
- 5y agoAWKNFBETRFBMBIFCYBN+16KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand ViewingPR NewswireNEW YORK, Oct. 18, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.
- 5y agoAWKNFBETRFBMBIFCYBN+13KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14thPR NewswireNEW YORK, Oct. 11, 2021 /PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming KCSA Psychedelics Virtual Investor Conference. Individual investors, institutional inves
- 5y agoWSNAFWesana Health to Present at the KCSA Psychedelics Virtual Investor Conference on October 14thPR NewswireCHICAGO, Oct. 11, 2021 /PRNewswire/ -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and im
- 5y agoWSNAFWesana Health Announces Inclusion in the AdvisorShares Psychedelics ETFGlobeNewswireCHICAGO and TORONTO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding
- 5y agoAVCNFBABYFCANSFFLHLF+2Life Sciences Companies Investor Presentations Now Available for On-Demand ViewingGlobeNewswireNEW YORK, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the September 16th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcase
- 5y agoWSNAFWesana Health Commits Funding of $1.5 Million To Support MAPS' Research PipelineGlobeNewswireMAPS to Investigate Viability of Research Pathway for MDMA-Assisted Therapy to Treat Traumatic Brain Injury Effort Positions MAPS, Sponsor of the Only Completed Phase 3 Trial for Psychedelic-Assisted Therapy, to Serve New Unique Role Within
- 5y agoAVCNFBABYFCANSFFLHLF+2Life Sciences Virtual Investor Conference: Company Executives Present Live September 16thGlobeNewswireNEW YORK, Sept. 10, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors, and industry professionals from around the world. This day-long virtual event will
- 5y agoWSNAFWesana Health Announces Closing of PsyTech AcquisitionGlobeNewswireCHICAGO and TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding,
- 5y agoWSNAFDistinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory BoardGlobeNewswireTORONTO and CHICAGO, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding,
- 5y agoWSNAFWesana Health Highlights Recent Appointments to Board of DirectorsGlobeNewswireTORONTO and CHICAGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF) is pleased to highlight the recent appointments of Robert Koffman, MD, MPH; Ian Burnstein; Mitch Kahn and George Mich
- 5y agoWSNAFWesana Health Commences Functional Animal Study for Treatment of Traumatic Brain InjuryGlobeNewswireTORONTO and CHICAGO, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. ("Wesana" or the "Company") (CSE:WESA, OTCQB:WSNAF), an emerging data driven life sciences company focused on developing innovative approaches for better understanding,